Evangelos Karavas

Title: Evangelos Karavas: Innovator in Pharmaceutical Formulations

Introduction

Evangelos Karavas is a notable inventor based in Pallini Attikis, Greece. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of medications. His innovative approach has led to the development of a unique pharmaceutical formulation that enhances the stability and effectiveness of active ingredients.

Latest Patents

Karavas holds a patent for a pharmaceutical formulation containing an HMG-COA reductase inhibitor. This formulation includes Fluvastatin, or its pharmaceutically acceptable salts, combined with a stabilizer made from a mixture of Carrageenans. The stabilizer plays a crucial role in inhibiting isomerization, elimination, oxidation, and recrystallization of the active ingredient, thereby improving its oral administration.

Career Highlights

Throughout his career, Karavas has focused on advancing pharmaceutical formulations to improve patient outcomes. His work has been recognized for its innovative approach to drug stability and efficacy. With a patent portfolio that includes 1 patent, he continues to contribute to the field of pharmaceuticals.

Collaborations

Karavas has collaborated with notable professionals in his field, including Efthimios Koutris and Elisavet Ioannidou. These collaborations have further enriched his research and development efforts, leading to advancements in pharmaceutical formulations.

Conclusion

Evangelos Karavas is a distinguished inventor whose work in pharmaceutical formulations has made a significant impact. His innovative patent demonstrates his commitment to improving drug stability and effectiveness. His contributions continue to influence the pharmaceutical industry positively.